Weight Maintenance After GLP-1s: Tips For Staying On Track
Published on: July 4, 2025
Weight Maintenance After Glp-1s: Tips For Staying On Track
Article author photo

Najmo Hassan

Article reviewer photo

Josie Hollywood

MBBS Medicine, Barts and the London

Overview 

Medications like Ozempic and Saxenda, also known as Glucagon-Like Peptide-1 (GLP-1) receptor agonists, have recently become widely used and increasingly popular due to their role in assisting with weight loss. They work by helping the body manage hunger, slowing how quickly food moves through the stomach, and supporting a better blood sugar balance. While many have experienced significant weight reduction during treatment, it can be difficult to maintain this weight loss once the medication.

Maintaining weight loss over time is dependent on building steady and realistic habits. With the right approach and practical tools, it is entirely possible to avoid regaining weight as well as support long-term wellbeing.

Why weight maintenance matters

Weight regain is common once GLP-1 medications are stopped, especially if no behavioural or lifestyle support is in place.1 When weight is regained rapidly, it might worsen insulin resistance, blood pressure, and lipid profiles, which can cause psychological distress or demotivation.2  Studies over time show that gradual withdrawal from medication, paired with proper lifestyle interventions, can greatly reduce the likelihood of rebound weight gain.3

It has also been highlighted how important it is for patients to be prepared for post-medication maintenance through education, support, and behavioural reinforcement.4 Given the global rise in obesity, public health initiatives increasingly focus on long-term strategies that go beyond short-term drug use.5

How GLP-1s work

Glucagon-like peptide 1 is a hormone naturally produced in the body which helps control blood sugar as well as appetite by:

  • Slowing stomach emptying
  • Increase feelings of fullness
  • Reducing hunger signals
  • Supporting insulin production and reducing glucagon secretion

GLP-1 medications imitate this hormone and therefore allow people to feel fuller for longer. As a result, people often eat less, which can contribute to gradual weight reduction. Studies have shown GLP-1 medications to produce 5-18% total body weight loss, and their benefits extend to improved cardiovascular and metabolic health when used consistently over time.6 However, when medication use stops, these appetite-regulating effects fade over time, which makes it easier to revert to previous eating patterns.7 

What happens when you stop taking GLP-1s?

When GLP-1 medication is stopped, the body slowly reverts to its natural hormone levels. This means:

  • Appetite may increase
  • Stomach emptying rate may speed up again
  • Food cravings can return
  • Weight regain is common if no lifestyle modifications are in place

This does not mean success is lost. A personalised mix of lifestyle habits and behaviour changes can help many people maintain their weight even when medication is stopped. Clinical studies show that people who combine pharmacological therapy with long-term behavioural support fare better after discontinuation.3,8 

Strategies for maintaining weight after GLP-1s

Establish a balanced eating pattern

Meals should combine a variety of nourishing components that help you stay fuller for longer:

This balance not only allows for a stable blood sugar level to be supported, but also helps manage appetite in a way that mimics some of the benefits experienced while taking GLP-1s.6 

Keep a consistent meal pattern

Eating regular and balanced meals three times a day, alongside planned snacks, can reduce the urge to overeat and help stabilise energy throughout the day. A predictable and easy-to-follow routine helps regulate energy as well as appetite more effectively.6,7 

Prioritise satisfying nutrients

Protein and fibre-rich foods play a key role in reducing hunger between meals. This might include options like lentils, Greek yoghurt, and chickpeas that are filling and help curb unexpected cravings without needing to rely on willpower alone. 

Keep moving

Staying physically active on a regular basis can help control appetite and reduce the chance of regaining weight.8 Activities that people can pick up to support this might include:

  • Walking, cycling, and swimming
  • Resistance training up to 3 times a week
  • Yoga or mindful stretching for mental and physical well-being

Improve sleep and stress management

A lack of sleep and consistently high stress levels can disrupt hormones like cortisol and ghrelin. These hormones can lead to increased hunger and cravings.9

So, the aim is:

  • 7-9 hours of sleep per night
  • Stress-reducing habits such as journaling, deep breathing, and regular breaks

Build a support network

Surrounding yourself with people or tools to support you allows you to stay on track and can make a real difference. To do this, you could consider:

  • Logging meals using an app or a notebook
  • Having regular check-ins with your healthcare team
  • Joining either local or online peer groups to find support and encouragement

Keep tabs on your progress

Tracking your progress and changes in weight, physical activity, or even mood can allow you to spot any patterns early. Using devices like watches or mobile apps can offer helpful insight and feedback to keep you moving towards your goals.

Tackle emotional eating

If emotional eating was a concern of yours, or contributing to your weight struggles before GLP-1 treatment, it is important to plan for it before stopping medication. After stopping the medication, some people can unfortunately find themselves returning to their old habits. This might be addressed by talking to a therapist, practising mindfulness, or finding a creative outlet to help manage those feelings.2,5 

Professional medical support

For some, especially those who have a history of metabolic issues or psychological concerns, it is important to continue seeking medical support. This might involve:6,9

  • Regular metabolic screenings to monitor blood sugar, cholesterol, or weight
  • Ongoing guidance from a registered dietitian
  • Behavioural support, such as cognitive behavioural therapy (CBT), to reinforce healthy patterns of thinking and behaviour

Raising public awareness

Educational efforts and community-based initiatives are important for breaking down stigma while promoting informed, realistic conversations around weight maintenance and medical support options. Encouraging dialogue about the role of medication, lifestyle, and support systems improves outcomes as well as promotes informed choices.5

Summary

GLP-1 receptor agonists are incredibly successful in initiating weight loss but they are not necessarily permanent or "quick" fixes. This is because true long-term success is likely dependent on sustainable and healthy lifestyle changes. These might include structured eating, regular movement, supporting emotional resilience, as well as proper professional support where needed to maintain weight loss once you have stopped taking a GLP-1 medication. Long-term success lies in treating weight maintenance as an evolving journey, one that blends structure, self-compassion, and support.

Frequently asked questions

What are GLP-1 medications?

GLP-1 receptor agonists are a type of medication that imitates hormones in the body. They help control appetite, support blood sugar levels, as well as slow digestion.

What should I expect after I stop taking a GLP-1 medication?

Initially, your appetite can return, which, if you are not prepared for, can make it easy to slip back into old habits. But many people can maintain their progress with lifestyle changes.

How do I stop the weight from coming back?

Focus on steady habits that are easy to maintain, such as eating balanced meals, staying active, managing stress levels and checking in with health professionals when needed.

Do I have to take GLP-1 forever?

Not necessarily. Some people do manage well without them, especially when supported by sustainable routines. However, others may benefit from periodic medical support.

Can emotional eating return?

It can, especially if medication was initially taken to help with stress-related cravings. Recognising those triggers and finding better, healthier ways to respond is important.

What kind of movement is the best?

Any kind that suits your lifestyle and feels good, whether that is walking, swimming or dancing etc. What is key is that it is regular and enjoyable.

Should I talk to a professional?

Yes! Whether it is your GP or a dietitian, they can help further personalise your plan and provide tools that fit your goals.

Can technology help me stay on track?

Yes! Any apps for food tracking, step counting, or mood journaling can help you stay focused and encouraged.

References

  1. Ard J, Fitch A, Fruh S, Herman L. Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists. Advances in Therapy. 2021;38(6): 2821-2839. https://doi.org/10.1007/s12325-021-01710-0.
  2. Gleason PP, Urick BY, Marshall LZ, Friedlander N, Qui Y, Leslie RS. Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. Journal of Managed Care & Specialty Pharmacy. 2024;20(8): 860=867.  https://doi.org/10.18553/jmcp.2024.23332.
  3. Reiss AB, Gulkarov S, Lau R, Klek SP, Srivastava A, Renna HA, et al. Weight reduction with GLP-1 agonists and paths for discontinuation while maintaining weight loss. Biomolecules. 2025;15(3): 408.  https://doi.org/10.3390/biom15030408.
  4. Paddu NU, Lawrence B, Wong S, Poon SJ, Srivastava G. Weight maintenance on cost-effective antiobesity medications after 1 year of GLP-1 receptor agonist therapy: a real-world study. Obesity. 2024;32(12): 2255-2263.  https://doi.org/10.1002/oby.24177.
  5. Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022;28(10): 2083-2091. https://doi.org/10.1038/s41591-022-02026-4.
  6. Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society. Obesity. 2025; oby.24336. https://doi.org/10.1002/oby.24336
  7. Wilding JP, Batterham RL, Davies M, Van Gaal LF, Kandler K, Kondakli K, LIngvay I, McGowan BM, ORal TK, Rosenstock J, Wadden TA. Weight regain and cardiometabolic effects after withdrawal of Semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8): 1553-1564. https://doi.org/10.1111/dom.14725.Reference
  8. Abdullah Bin Ahmed, I. A comprehensive review on weight gain following discontinuation of glucagon-like peptide-1 receptor agonists for obesity. Journal of Obesity. 2024;2024: 1-8.  https://doi.org/10.1155/2024/8056440.
  9. Moore PW, Malone K, VanValkenburg D, Rando LL, Williams BC, Matejowsky HG, et al. GLP-1 agonists for weight loss: pharmacology and clinical implications. Advances in Therapy. 2023;40(3): 723-742. https://doi.org/10.1007/s12325-022-02394-w.

Share

Najmo Hassan

Bachelor's, Biomedical Sciences, University of Dundee

arrow-right